EPIRUS Biopharmaceuticals, Inc. - FORM 10-Q - EX-32.1 - SECTION 906 PEO AND PFO CERTIFICATION - May 12, 2010

Attached files

file filename
EX-31.2 - SECTION 302 PFO CERTIFICATION - EPIRUS Biopharmaceuticals, Inc.dex312.htm
EX-31.1 - SECTION 302 PEO CERTIFICATION - EPIRUS Biopharmaceuticals, Inc.dex311.htm
EX-10.13 - SEPARATION AGREEMENT - EPIRUS Biopharmaceuticals, Inc.dex1013.htm
EX-10.42 - AGREEMENT BY & AMONG MALLINCKRODT INC. - EPIRUS Biopharmaceuticals, Inc.dex1042.htm
10-Q - FORM 10-Q - EPIRUS Biopharmaceuticals, Inc.d10q.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO

SECTION 1350, CHAPTER 63 OF TITLE 18, UNITED STATES CODE,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to Section 1350, Chapter 63 of Title 18, United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, as principal executive officer and principal financial officer of CombinatoRx, Incorporated (the “Company“), do hereby certify that to their knowledge:

 

  1) the Company’s Form 10-Q for the fiscal quarter ended March 31, 2010 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  2) the information contained in the Company’s Form 10-Q for the fiscal quarter ended March 31, 2010 fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ Mark H. N. Corrigan

Mark H. N. Corrigan
President and Chief Executive Officer
(principal executive officer)

/s/ Justin A. Renz

Justin A. Renz
Senior Vice President and Chief Financial Officer
(principal financial officer)

Dated: May 12, 2010

Stock widget

Investing forum

EPIRUS Biopharmaceuticals, Inc. Reports